CIDETEC is a private organization for applied research founded in 1997 that seeks to contribute value to companies by harnessing, generating and transferring technological knowledge. Member of the Basque Research and Technology Alliance, CIDETEC is comprised of three international technological reference institutes in energy storage, surface engineering and nanomedicine. CIDETEC currently employs a workforce of 183, 95% of whom are university graduates and 45% PhD holders. Its volume of activity came up to € 13M in 2019.
CIDETEC Nanomedicine is devoted to the development of innovative materials in the field of biomedicine. The institute research model is based on generating its own innovative technology (currently 5 patents from 4 product families). Its direct contact with industry enables to complete technology transfer, via IP licensing, reducing time to market. The team is specialized in the synthesis and characterization of biomaterials in general, and nanomaterials in particular, with a big focus on drug delivery systems and medical devices. In the last years, with the objective of facilitating the transfer of nanotechnology to the market, CIDETEC Nanomedicine has established two pilot plants operating under GMP for both pharma and cosmetic industries.
Main task in the project
- CID will produce new capsules as cmRNA delivery vehicle following patented technology in (WP2).
- CID will support and define the requirements for production of GMP-like delivery systems and batches (WP2 and 3).
- CID will support the characterization and incorporation of the nanocapsules into the matrices (WP3 and 4).
- Contribute to the exploitation and management of the project (WP 9).